Skip to content
Screener

Pulse Biosciences, Inc. PLSE Q2 2026 earnings

Reported August 6, 2026 · After market close

Revenue$434.0KMiss by $99.3K
EPS-$0.36Miss by $0.07
Revenue estimate$533.3K
EPS estimate-$0.29
“This was a highly productive quarter for Pulse Biosciences, defined by exceptional momentum in our cardiac catheter program. We have recently surpassed the halfway point of enrollment in our U.S. pivotal NANOPULSE-AF study, and even after expanding the enrollment target by 19 patients, we continue to anticipate completing enrollment by early Q4. The catheter's ease of use, seamless workflow integration and its demonstrated safety and durability outcomes are driving rapid progress in the study. Together with a meaningfully strengthened balance sheet, we are well positioned to advance the clinical and regulatory milestones that will bring the transformative potential of nanosecond PFA technology to patients and physicians globally.”
Paul LaViolette

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$620.0K
EPS estimate-$0.35

Financials

Q2 2026

Income statement

See full
Revenue$434.0K—
Gross profit$161.0K—
Operating income-$25.3M-24.6%
Net income-$24.7M-28.6%

Balance sheet

See full
Cash & equivalents$101.6M-4.4%
Total debt$6.8M-17.9%
Total equity$99.5M-4.8%
Total assets$115.6M-3.9%

Cash flow

See full
Operating cash flow-$18.7M-46.1%
CapEx$90.0K-12.6%
Free cash flow-$18.8M-45.6%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$3.54B+223%
Enterprise value$3.44B+245%
P/S2,985.9×—

Profitability

See full
Gross margin-0.1%—
Operating margin-7,007.8%—
Net margin-6,755.8%—
FCF margin-5,180.4%—

Returns & leverage

See full
Return on equity-78.5%-15.3pp
Debt / equity0.1×0.0×
Current ratio9.6×-2.4×

Segments

By segment

See full
Single Reportable$434.0K—

FAQ

When did Pulse Biosciences, Inc. report Q2 2026 earnings?
Pulse Biosciences, Inc. (PLSE) reported Q2 2026 earnings on August 6, 2026 after market close.
What were Pulse Biosciences, Inc.'s Q2 2026 revenue and EPS?
Pulse Biosciences, Inc. reported revenue of $434.0K and eps of $-0.36 for Q2 2026.
Did Pulse Biosciences, Inc. beat estimates in Q2 2026?
Revenue missed the consensus estimate of $533.3K by $99.3K. EPS missed the consensus estimate of $-0.29 by $0.07.
How did Pulse Biosciences, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 28.6% from $-0.28.
Where can I find Pulse Biosciences, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001437749-26-026256) and the 10-Q periodic report (0001437749-26-026288) directly on SEC EDGAR. The filing index links above go to sec.gov.